Yu-Ning Wong, MD MSCE
Professor of Clinical Medicine (Hematology-Oncology)
Department: Medicine
Contact information
Corporal Michael J. Crescenz Veterans Affairs Medical Center
3800 Woodland Avenue
Medicine Service, Hematology Oncology Section
Philadelphia, PA 19104
3800 Woodland Avenue
Medicine Service, Hematology Oncology Section
Philadelphia, PA 19104
Office: 2158235800x205999
Education:
BA
University of Virginia, 1995.
MD
University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, 1999.
MS (Clinical Epidemiology)
University of Pennsylvania, 2006.
Permanent linkBA
University of Virginia, 1995.
MD
University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, 1999.
MS (Clinical Epidemiology)
University of Pennsylvania, 2006.
Description of Clinical Expertise
Genitourinary MalignanciesDescription of Research Expertise
Cancer treatment outcomesCancer treatment decision making
Genitourinary Malignancies
Selected Publications
Brian L Egleston, Mary Daly, Kaitlyn Lew, Lisa Bealin, Alexander D Husband, Jill E Stopher, Pawel Przybysz Olga Tchuvatkina,Yu-Ning Wong, Judy Garber, Timothy Rebbeck: Changes in risk tolerance for ovarian cancer prevention strategies during the Covid-19 pandemic: Results of a discrete choice experiment. Medical Decision Making 2024.Lin JK, Hearn CM, Getzen E, Long Q, Lee DC, Keaveny TM, Jayadevappa R, Robinson KW, Wong YN, Maxwell KN, Narayan V, Haas NB, Takvorian SU, Bikle DD, Chiang JM, Khan AN, Rajapakse CS, Morgans AK, Parikh RB.: Validation of Biomechanical Computed Tomography for Fracture Risk Classification in Metastatic Hormone Sensitive Prostate Cancer European Urology Oncology 23, November 2023.
Shevach JW, Aiello LB, Lynch JA, Petersen J, Hoffman-Hogg L, Hartzfeld D, Lundquist M, Kelley MJ, Scheuner MT, Montgomery R, Damjanov N, Robinson K, Wong YN, Jhala D, Parikh RB, Maxwell KN.: On-Site Nurse-Led Cancer Genetics Program Increases Cancer Genetic Testing Completion in Black Veterans. JCO Oncol Pract 19(8): 637-644, August 2023.
Danielle Candelieri-Surette, Hung A ,Lynch JA, Pridgen KM, FY Agiri, Li W, Aggarwal H, Anglin-Foote T, Lee KM, Perez C, Reed S, DuVall SL, Wong Y, Alba PR : Development and Validation of a Tool to Identify Patients Diagnosed With Castration-Resistant Prostate Cancer. JCO Clinical Cancer Informatics(7), 2023.
Nickols NG, Mi Z, DeMatt E, Biswasm K, Clise CE, Huggins JT, Maraka S, Ambrogini E, Mirsaeidi MS, Levin ER, Becker DJ, Makarov DV, Febles VA, Belligund PM, Al-Ajam M, Muthiah MP, Montgomery RB, Robinson KW, Wong YN, Bedimo RJ, Villareal RC, Aguayo SM, Schoen MW, Goetz MB, Graber CJ, Bhattacharya D, Hoo GS Orshansky g, Norman LE, Tran S, Ghayouri L, Tsai S, Geelhoed M, Rettig MB : Effect of Androgen Suppression on Clinical Outcomes in Hospitalized Men With COVID-19: The HITCH Randomized Clinical Trial. JAMA Network Open 5(4): e227852, April 2022.
Song A, Bange EM, Kavanagh R, Savinese S, Way D, Wong Y, Haley E: Hospice Care of Veterans Receiving Concurrent Immunotherapy: Clinical Challenges and Opportunities for Improvement. American Academy of Hospice and Palliative Medicine, Virtual meeting. Feb 2022 Notes: "Oral Presentation"
Yamoah K, Lee KM, Awasthi S, Alba PR, Perez C, Anglin-Foote TR, Robison B, Gao A, DuVall SL, Katsoulakis E, Wong YN, Markt SC, Rose B, Burri R, Wang C, A Okoduwa, Fink AK, Nickols NG, Lynch JA, Garraway IP: Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System. JAMA Network Open 5(1): e2144027, Jan 2022.
Parikh RB, Gallo JJ, Wong YN, Robinson KW, Cashy JP, Narayan V, Jayadevappa R, Chhatre S.: Long-term depression incidence and associated mortality among African American and White prostate cancer survivors. Cancer 127(18): 3476-3485, Sep 2021.
Hungria V, Martínez-Baños DM, Peñafiel CM, Miguel CE, Jorge Vela-Ojeda5, Remaggi G, Duarte FB, Cao C, Cugliari MS,Santos T, Machnicki G, Fernandez, M, Grings M, Ammann EM, Lin JH, Chen, Y-W, Wong, Y-N, Barreyro P. : Multiple Myeloma Treatment Patterns and Clinical Outcomes in the Latin America Hemato-Oncology (HOLA) Observational Study, 2008-2016. Br J Haematol. 188(3): 383-393, Feb 2020.
Li P, Jahnke J, Pettit AR, Wong YN, Doshi JA: Comparative Survival Associated With Use of Targeted vs Nontargeted Therapy in Medicare Patients With Metastatic Renal Cell Carcinoma. JAMA Netw Open 2(6): e195806, Jun 5 2019.